Search by Drug Name or NDC

    NDC 41163-0117-01 equaline lansoprazole 15 mg/1 Details

    equaline lansoprazole 15 mg/1

    equaline lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Supervalu Inc. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 41163-0117
    Product ID 41163-117_a9daca89-e2f8-40bf-9beb-4267aaac7d3e
    Associated GPIs 49270040006510
    GCN Sequence Number 030106
    GCN Sequence Number Description lansoprazole CAPSULE DR 15 MG ORAL
    HIC3 D4J
    HIC3 Description PROTON-PUMP INHIBITORS
    GCN 01697
    HICL Sequence Number 008993
    HICL Sequence Number Description LANSOPRAZOLE
    Brand/Generic Generic
    Proprietary Name equaline lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Supervalu Inc
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202319
    Listing Certified Through 2023-12-31

    Package

    NDC 41163-0117-01 (41163011701)

    NDC Package Code 41163-117-01
    Billing NDC 41163011701
    Package 1 BOTTLE in 1 CARTON (41163-117-01) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2012-05-21
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL ea8efda5-9d08-446b-9424-68a98122589a Details

    Revised: 3/2020